169166 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites
Biological state-evaluating apparatus, biological state-evaluating method, biological state-evaluating system, biological state-evaluating program, evaluation function-generating apparatus, evaluation function-generating method, evaluation function-generating program and recording medium
#302Drugs For Diseases Accompanying Changes In Total Bile Acid Pool Or Lipid Metabolism Disorders And Method Of Screening These Drugs
#303CRAC modulators and use of same for drug discovery
#304Withanolide compounds as inhibitors of fibrosis and identification of molecular targets for anti-fibrotic drug development
#305Cell analysis apparatus and method
#306Dual-Transfected Cells Lines As In Vitro Screening Tools For Pharmaceutical Compound Profiling: A Model For The Heptobiliary Elimination
#307Methods of Validating Target for Modulating Insulin Action, Screening for Modulators of Insulin Action and Therapeutic Uses Thereof
#308Reagents and methods for using human embryonic stem cells to evaluate toxicity of pharmaceutical compounds and other chemicals
#309Kinetic metabolic assay for antifungal susceptibility testing
#310Materials and methods for identifying agents that modulate Norrin, Norrin mimetics, and agents identified thereby
#311Method and compositions for identifying anti-hiv therapeutic compounds
#312Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#313Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#314Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#315Prediction method for lipidosis
#316PTH receptor and screening assay utilizing the same
#317Relationship of a specific metabolite to insulin resistance
#318Analysis of metabolic activity in cells using extracellular flux rate measurements
#319Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#320Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds
#321Apparatus and method for analyzing a metabolite profile
#322Device for quantitative analysis of a drug or metabolite profile
#323Ion channel assay methods
#324Methods for identifying cell surface receptor protein modulators
#325Simultaneous detection of metabolic enzyme activity and metabolite levels
#326Ion channel assay methods
#327Metabonomics homogeneity analysis
#328Metabolic-based methods for modulating gene expression
#329Compositions for modulation of PARP and methods for screening for same
#330Data correction, normalization and validation for quantitative high-throughput metabolomic profiling
#331Laminated cell culture containing hepatocytes and method for detecting endocrine-like substance
#332Glucose-transport related genes, polypeptides, and methods of use thereof
#333Methods and systems for indentifying and monitoring S-nitrosothiols in biological samples
#334Human hepatocyte-like cells and uses thereof
#335Precursor conversion screening method
#336Methods for drug discovery disease treatment, and diagnosis using metabolomics
#337Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#338Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#339Non nucleoside reverse transcriptase inhibitors
#340Method and compositions for identifying anti-hiv therapeutic compounds
#341Device and method for non-invasive measurement of the individual metabolic rate of a substantially spherical metabolizing particle
#342Apparatus and methods for using biological material to discriminate an agent
#343Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#344Method of determining toxicity with three dimensional structures
#345Determining coping capacity after exposure to a psychological stressor
#346Method for detecting reactive metabolites using a combination of glutathione and a stable isotopic derivative of glutathione and mass spectroscopy-based pattern recognition
#347Compounds which modulate amyloidogenesis and methods for their identification and use
#348Method and compositions for identifying anti-HIV therapeutic compounds
#349Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds
#350Non nucleoside reverse transcriptase inhibitors
#351Device and methods for measuring the response of a least one cell to a medium
#352System and methods for discriminating an agent
#353Device and methods for monitoring the status of at least one cell
#354Fourier transform mass spectrometry of complex biological samples
#355Modulation of line-1 reverse transcriptase
#356Metabolic phenotyping
#357Potentiators of insulin secretion
#358Diagnostic method based on lipid measuring parameter modulations/effector quotient profiles
#359PDE 10 cell-based assay and sequences
#360Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#361Device and methods for detecting the response of a plurality of cells to at least one analyte of interest
#362Detection and modification of gut microbial population